MOREPENLAB

What Morepen Laboratories promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q4 FY25

what the last two calls moved 15 tracked 3 delivered 4 missed 8 open
  • Medical Devices Revenue delivered, diluted said Q2 FY25 Promised: INR 540-545 crores for FY25 Q4 FY25: Achieved INR 496 crores, beating the revised target but missing the original.
  • Overall Revenue Growth missed said Q1 FY25 Promised: 15-20% for FY25 Q4 FY25: Achieved 7.4% growth in FY25, explicitly stating it was 'lower than expected'.
  • Glucometer Capacity revised down said Q1 FY25 Promised: Increase from 2.5 million to 5 million in 12-18 months Q4 FY25: Revised target down to 3.6 million units.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 15 tracked commitments for Morepen Laboratories — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens